2021 News

Catapult Ventures records 3.3x return from exit of Panthera Biopartners

28 April 2022 - Manchester, UK.  The GM&C Life Sciences Fund, managed by Catapult Ventures, has announced a 3.3x cash return (115.6% IRR), from its exit of Panthera Biopartners Ltd. The exit comes as part of a £10m further fu...

Medicine switching expert Maxwellia continues to drive shift to self-care with two more pharmacy products in the launch pipeline

MANCHESTER, England, April 22, 2022 /PRNewswire/ -- Following the reclassification of the daily progestogen-only pill earlier this year, Maxwellia made history by launching Lovima® (desogestrel 75mcg) one of the first ora...

Proveca announces agreement with Biopas Laboratories

Proveca Ltd is excited to announce a significant agreement outside Europe with Biopas Laboratories based in Colombia.  Biopas will commercialise and distribute Sialanar® exclusively throughout Spanish speaking territories in South...

From our portfolio

Pronec

Pharmaceuticals

viewview our portfolio

Our Team

Nick Wright

CEO

view complete team

Contact us

Tel: 01625 344300

email